Does it matter how remission is achieved in acute leukemia?

Leukemia

Volumn 10, Issue SUPPL. 1, 1996, Pages

  Bishop, James F ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Acute leukemia; Australian Leukemia Study Group; Remission

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; BLAST CELL; BLOOD TOXICITY; BONE MARROW DEPRESSION; CANCER REGRESSION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; EYE TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; NAUSEA; NEUROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; THROMBOCYTOPENIA; VOMITING;

EID: 0029883775     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Bishop JF, Lowenthal RM, Joshua D, Mathews JP, Todd D, Cobcroft R, Whiteside MG, Kronenberg H, Ma D, Dodds A, for the Australian Leukemia Study Group. Etoposide in acute nonlymphocytic leukemia. Blood 1990; 75: 27-32.
2. Bishop JF, Matthews JP, Young C, Szer J, Joshua DE, Dodds A, Laidlaw CR, Cobcroft R, Herrman R, Ma D. The influence of induction chemotherapy dose and dose intensity on the duration of remission in acute myeloid leukemia. Leuk Lymphoma 1994; 15: 79-84.
3. Hines JD, Oken MM, Mazza JJ, Koller AM, Streeter RR, Glick JH. High-dose cytarabine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia., J Clin Oncol 1984; 2: 545-549.
4. Bishop JF, Matthews JP, Young GA, Szer J, Page A. A randomized trial of high dose cytarabine in induction in acute myeloid leukemia. Blood (in press) 1996.
5. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E III. Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 1994; 331: 896-903.
6. Bishop JF. Intensified therapy for acute myeloid leukemia. N Engl J Med 1994; 331: 941-942.